The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
4D MOLECULAR THERAPEUTICS IN COM 35104E100 13,052 300,886 SH   SOLE   300,886 0 0
AMRYT PHARMA PLC SPONSORED ADS 03217L106 11,144 800,000 SH   SOLE   800,000 0 0
ARGENX SE SPONSORED ADR 04016X101 5,838 21,200 SH   SOLE   21,200 0 0
ARROWHEAD PHARMACEUTICALS IN COM 04280A100 27,050 407,926 SH   SOLE   407,926 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109 41,129 423,012 SH   SOLE   423,012 0 0
DICERNA PHARMACEUTICALS INC COM 253031108 43,607 1,705,392 SH   SOLE   1,705,392 0 0
GALAPAGOS NV SPON ADR 36315X101 8,998 116,723 SH   SOLE   116,723 0 0
GENMAB A/S SPONSORED ADS 372303206 3,940 120,000 SH   SOLE   120,000 0 0
HARPOON THERAPEUTICS INC COM 41358P106 32,514 1,554,199 SH   SOLE   1,554,199 0 0
MAGENTA THERAPEUTICS INC COM 55910K108 29,626 2,502,210 SH   SOLE   2,502,210 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 32,682 1,124,237 SH   SOLE   1,124,237 0 0
PIERIS PHARMACEUTICALS INC COM 720795103 9,446 3,675,530 SH   SOLE   3,675,530 0 0
REGENXBIO INC COM 75901B107 19,083 559,444 SH   SOLE   559,444 0 0
SPDR S&P 500 ETF TR UNIT 78462F103 118,899 300,000 SH Put SOLE   0 0 300,000
SPDR S&P BIOTECH ETF TR UNIT 78464A870 67,825 500,000 SH Put SOLE   0 0 500,000
SPERO THERAPEUTICS INC COM 84833T103 56,366 3,829,209 SH   SOLE   3,829,209 0 0
UNIQURE NV SHS N90064101 32,188 955,424 SH   SOLE   955,424 0 0